Cheraw Chronicle

Complete News World

Pan American Health Organization board discusses access to monkeypox vaccine in region - Dagblad Suriname

Pan American Health Organization board discusses access to monkeypox vaccine in region – Dagblad Suriname

As monkeypox cases continue to rise in many countries in the Pan American region, member states of the Pan American Health Organization (PAHO) held a special board meeting on Monday, August 8 to consider a resolution to address the outbreak, including support for equitable access to vaccines for vulnerable groups. danger in the region.

On July 23, the director of the World Health Organization (WHO) declared the outbreak, which began in mid-May and affected 89 countries in all six WHO regions, and is a public health emergency of international concern. – PHEIC).

About 10,000 cases of monkeypox have been reported in 24 countries in the Pan American region since the outbreak began. This represents 36% of global cases.

“The Primary Health Emergency Statement (PHEIC) was accompanied by detailed recommendations for both countries and territories that had not yet identified cases and countries and territories that had already imported cases or transmission in their communities,” said Carissa Etienne, director of the Pan American Health Organization.

“We believe that when the recommended measures are implemented correctly, we can stop the transmission of monkeypox virus.”

These recommendations, which the PAHO is implementing with member states, include communication and engagement with affected communities, early detection and monitoring, treatment and isolation of patients, and contact tracing.

However, the director added that “post- or pre-exposure vaccination” may need to complement other procedures.

During the hearing, Dr. Etienne noted that there is currently only a third generation monkeypox vaccine, which is produced by only one plant.

Although stocks of this vaccine are very limited, the Pan American Health Organization has begun negotiations with its manufacturer.

See also  Hydrogel keeps vaccination fluid nice and cool at low cost

In light of this, the resolution called on the Director of the Pan American Health Organization to facilitate a coordinated response and to take steps to support Member States in obtaining this vaccine through the PAHO Revolving Fund. Countries in the Pan American region are also requested to continue to recognize the Pan American Health Organization and its revolving fund as the most appropriate strategic regional technical mechanism for providing equitable access to this and other vaccines.

The recommendations of the PAHO Technical Advisory Group on Vaccine-Preventable Diseases, as well as those of the International Health Regulations Emergency Committee convened by the World Health Organization (WHO), require countries to prioritize vaccines for certain groups, such as people who are in close contact with a person Certain. Monkeypox, in order to maximize the effect given the limited supply of vaccines.

monkeypox disease

Monkeypox is a zoonotic viral disease caused by the monkeypox virus. Symptoms include fever, severe headache, swollen lymph nodes, muscle aches, and a rash that forms blisters and scales. The rash is usually concentrated on the face and palms. The mouth, genitals, and eyes may also be affected.

Symptoms can be mild or severe, and usually last for several weeks, during which time one can be contagious to others. Most people recover without treatment within a few weeks.

Monkeypox has been reported regularly in nine countries in Central and West Africa since it was first identified in the Democratic Republic of the Congo in 1958. However, since mid-May 2022, an increasing number of monkeypox cases have been reported, first in several Countries in Europe and later in other regions, including the Americas.

See also  “We will have to invest in climate adaptation: giving water space again” - Belgium

As of August 4, 2022, 26,326 probable and laboratory-confirmed cases have been reported to WHO from 89 countries in all six WHO regions.